S80251 |
Romidepsin (FK228, Depsipeptide) |
源葉(MedMol) | 99% |
- 提示:詳情請(qǐng)下載說(shuō)明書。
- 產(chǎn)品描述: Romidepsin (FK 228) is a Histone deacetylase (HDAC) inhibitor with anti-tumor activities. Romidepsin (FK 228) inhibits HDAC1, HDAC2, HDAC4, and HDAC6 with IC50s of 36 nM, 47 nM, 510 nM and 1.4 μM, respectively. Romidepsin (FK 228) is produced by Chromobacterium violaceum, induces cell G2/M phase arrest and apoptosis
- 靶點(diǎn): HDAC1:36 nM (IC50);HDAC2:47 nM (IC50);HDAC4:510 nM (IC50);HDAC6:14000 nM (IC50);Apoptosis;HDAC
- 體內(nèi)研究:
Romidepsin (intraperitoneal injection; 0.5 and 1 mg/kg; every 3 day; 21 days) inhibited the tumor growth, reveals a higher expression of p-cdc25C, ki67, c-caspase-3 and c-PARP, and a lower expression of Ki-67 in Romidepsin treated tumors
- 參考文獻(xiàn):
1. Furumai R, et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 2002 Sep 1;62(17):4916-21. 2. Sun WJ, et al. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells. Biochem Pharmacol. 2017 Mar 1;127:90-100.
- 溶解性: DMSO : ≥ 100 mg/mL (184.95 mM)
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.849 ml 9.247 ml 18.495 ml 5 mM 0.37 ml 1.849 ml 3.699 ml 10 mM 0.185 ml 0.925 ml 1.849 ml 50 mM 0.037 ml 0.185 ml 0.37 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)